232 related articles for article (PubMed ID: 25540389)
1. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.
Xu J; Li L; Yu G; Ying W; Gao Q; Zhang W; Li X; Ding C; Jiang Y; Wei D; Duan S; Lei Q; Li P; Shi T; Qian X; Qin J; Jia L
Mol Cell Proteomics; 2015 Mar; 14(3):499-509. PubMed ID: 25540389
[TBL] [Abstract][Full Text] [Related]
2. CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway.
Saito N; Sakakibara K; Sato T; Friedman JM; Kufe DW; VonHoff DD; Kawabe T
Mol Cancer Ther; 2014 Dec; 13(12):3013-23. PubMed ID: 25253782
[TBL] [Abstract][Full Text] [Related]
3. The Cullin-3-Rbx1-KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB.
Kovačević I; Sakaue T; Majoleé J; Pronk MC; Maekawa M; Geerts D; Fernandez-Borja M; Higashiyama S; Hordijk PL
J Cell Biol; 2018 Mar; 217(3):1015-1032. PubMed ID: 29358211
[TBL] [Abstract][Full Text] [Related]
4. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
[TBL] [Abstract][Full Text] [Related]
5. Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.
Yu Q; Hu Z; Shen Y; Jiang Y; Pan P; Hou T; Pan ZQ; Huang J; Sun Y
Neoplasia; 2020 Apr; 22(4):179-191. PubMed ID: 32145688
[TBL] [Abstract][Full Text] [Related]
6. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
7. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
[TBL] [Abstract][Full Text] [Related]
8. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
9. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
Lan H; Tang Z; Jin H; Sun Y
Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
[TBL] [Abstract][Full Text] [Related]
10. Cullin neddylation may allosterically tune polyubiquitin chain length and topology.
Onel M; Sumbul F; Liu J; Nussinov R; Haliloglu T
Biochem J; 2017 Feb; 474(5):781-795. PubMed ID: 28082425
[TBL] [Abstract][Full Text] [Related]
11. SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1).
Huang G; Stock C; Bommeljé CC; Weeda VB; Shah K; Bains S; Buss E; Shaha M; Rechler W; Ramanathan SY; Singh B
J Biol Chem; 2014 Dec; 289(50):34728-42. PubMed ID: 25349211
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells.
Luo Z; Pan Y; Jeong LS; Liu J; Jia L
Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CRL-NEDD8 pathway as a new approach to enhance ATRA-induced differentiation of acute promyelocytic leukemia cells.
Liu S; Wan J; Kong Y; Zhang Y; Wan L; Zhang Z
Int J Med Sci; 2018; 15(7):674-681. PubMed ID: 29910671
[TBL] [Abstract][Full Text] [Related]
14. Neddylation-induced conformational control regulates cullin RING ligase activity in vivo.
Boh BK; Smith PG; Hagen T
J Mol Biol; 2011 Jun; 409(2):136-45. PubMed ID: 21463634
[TBL] [Abstract][Full Text] [Related]
15. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
[TBL] [Abstract][Full Text] [Related]
16. Cullin RING Ligase 5 (CRL-5): Neddylation Activation and Biological Functions.
Zhang S; Sun Y
Adv Exp Med Biol; 2020; 1217():261-283. PubMed ID: 31898233
[TBL] [Abstract][Full Text] [Related]
17. Protein neddylation: beyond cullin-RING ligases.
Enchev RI; Schulman BA; Peter M
Nat Rev Mol Cell Biol; 2015 Jan; 16(1):30-44. PubMed ID: 25531226
[TBL] [Abstract][Full Text] [Related]
18. Overactivated neddylation pathway as a therapeutic target in lung cancer.
Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
[TBL] [Abstract][Full Text] [Related]
19. Rbx1 flexible linker facilitates cullin-RING ligase function before neddylation and after deneddylation.
Liu J; Nussinov R
Biophys J; 2010 Aug; 99(3):736-44. PubMed ID: 20682250
[TBL] [Abstract][Full Text] [Related]
20. Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization.
Chen C; Gu L; Matye DJ; Clayton YD; Hasan MN; Wang Y; Friedman JE; Li T
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
